A New Era in Microbiome-Based Treatment: REBYOTA for Clostridium difficile Infection
Introduction Clostridium difficile infection (CDI) continues to be a formidable public health challenge, particularly within hospital and long-term care settings. Characterized by severe diarrhea, colitis, and potentially life-threatening complications, CDI poses significant risks, especially to vulnerable patient populations. Traditional antibiotic therapies, though effective initially, often...
0 Commenti 0 condivisioni 4K Views 0 Anteprima
Pubblicità